Our Work

Despite the devastating toll of the overdose crisis in the United States, many addiction treatment programs do not offer medications for opioid use disorder (MOUD).

Gene and RNA therapies are promising treatments for many rare diseases. Pediatric populations that could benefit from these drugs are overrepresented among state Medicaid programs.

Earth Day was the perfect occasion for the Hopkins Business of Health Initiative (HBHI) to host a first-of-its-kind conversation with HHS Secretary Xavier Becerra about addressing healthcare’s climate footprint in the context of environmental justice.